Frequency News and Research

RSS

New guidelines on the management of antithrombotic agents for endoscopic procedures published

According to a new guideline from the American Society for Gastrointestinal Endoscopy (ASGE) regarding the management of antithrombotic agents for endoscopy, aspirin and/or NSAIDs may be continued for all elective endoscopic procedures.

9 Dec 2009

New Medical Design Partner Specialist joins Microchip Technology's program

Microchip Technology Inc., a leading provider of microcontroller and analog semiconductors, today announced a new Medical Design Partner Specialist. TechEn, Inc. joins Microchip’s program of more than 14 Design Partner Specialists in areas such as medical electronics, Radio-Frequency (RF) design and touch sensing.

9 Dec 2009

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

Brian Newman, MD, FRCS, will conduct two training sessions for medical professionals on the Veinwave(TM) system, a revolutionary system used by doctors around the world to non-invasively eliminate spider veins and telangiectasia.

9 Dec 2009

NeuroPace announces clinical trial results demonstrating the RNS System

NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS- System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.

9 Dec 2009

Despite rising costs of U.S. health care, quality lags in ambulatory care

Most primary care physicians active in the Medicare program work in practices with too few patients to reliably measure significant differences in common measures of quality and cost performance, according to a study in the December 9 issue of JAMA.

9 Dec 2009

Soy food associated with lower risk of death and breast cancer recurrence, says new study

Researchers at Vanderbilt-Ingram Cancer Center, led by Xiao Ou Shu, M.D., Ph.D., professor of Medicine, have found that a higher intake of soy foods was associated with a lower risk of death and breast cancer recurrence among breast cancer patients in China. The study is published in the December 9 issue of JAMA.

9 Dec 2009

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

Results of two new studies support the use of the intravenous formulation of the antiepileptic drug (AED) Vimpat® for patients requiring add-on therapy in clinical settings where oral AED therapy is temporarily not feasible.

8 Dec 2009

NeuroPace's RNS System effective for controlling seizures not treatable by medication in epilepsy patients

NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.

8 Dec 2009

Long-chain omega-3 fatty acids can prevent colorectal cancer

Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9, 2009, in Houston.

8 Dec 2009

Non-clinical data of CK-2017357 presented by Cytokinetics

Cytokinetics, Incorporated announced today that both a poster and an oral presentation summarizing non-clinical data regarding CK-2017357, a novel fast skeletal troponin activator, were presented at the 5th Cachexia Conference, organized by the Society on Cachexia and Wasting Disorders, being held December 5-8, 2009 in Barcelona, Spain.

8 Dec 2009

$225,000 funding for promising epilepsy research

The Epilepsy Research Foundation (ERF), a unique joint venture of non-profit epilepsy organizations, and the Milken Family Foundation, a private philanthropic foundation, today announced two new grants recognizing promising epilepsy research in clinical development, totaling $225,000 in funding. The grant awards were announced by the Epilepsy Therapy Project and the Epilepsy Foundation, as well as the Milken Family Foundation, during the 7th Judith Hoyer Lecture in Epilepsy at the annual meeting of the American Epilepsy Society in Boston, MA.

7 Dec 2009

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML) were presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana (ASH Abstract # 1033).

7 Dec 2009

Gloucester Pharmaceuticals to be acquired by Celgene

Celgene Corporation and Gloucester Pharmaceuticals Inc., a privately held pharmaceutical company, announced a definitive merger agreement under which Celgene Corporation will acquire Gloucester Pharmaceuticals. Celgene says the acquisition will continue to advance its leadership position in the development of disease-altering therapies through innovative approaches for patients with rare and debilitating blood cancers.

7 Dec 2009

UCB presents data on Vimpat AED at AES meeting

UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.

7 Dec 2009

Scientists identify aggression-promoting pheromone in flies’ antenna

Have you ever found yourself struggling to get your order taken at a crowded bar or lunch counter, only to walk away in disgust as more aggressive customers elbow their way to the front? It turns out that flies do much the same thing, according to biologists from the California Institute of Technology (Caltech).

7 Dec 2009

Researchers explore optimal induction therapies for managing blood cancer

There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in order to discover new treatment options and provide patients with the best care.

7 Dec 2009

DBS therapy offers hope for epilepsy patients

Long-term data from an investigational study of Deep Brain Stimulation (DBS) Therapy for Epilepsy was released this week by Medtronic, Inc. (NYSE:MDT) at the American Epilepsy Society Meeting (AES) in Boston.

7 Dec 2009

NPA responds to DEA's steroid classification action

"The Natural Products Association and its members are very excited to see the DEA use the additional power the NPA and many others worked so hard to give to it through the Anabolic Steroid Control Act of 2004.

5 Dec 2009

AES: Progress in epilepsy management not reached millions of people around the world

Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.

5 Dec 2009

Radio units help in optimizing medical device management in hospitals

Have the blood supplies got too warm? Do they match the patient's blood group? In the future, these kinds of questions will be answered by intelligent radio nodes attached to blood bags. These radio units will also greatly facilitate device management in hospitals.

5 Dec 2009

Frequency News and Research

New guidelines on the management of antithrombotic agents for endoscopic procedures published

New Medical Design Partner Specialist joins Microchip Technology's program

Dr. Brian Newman to conduct two training sessions for medical professionals on Veinwave system

NeuroPace announces clinical trial results demonstrating the RNS System

Despite rising costs of U.S. health care, quality lags in ambulatory care

Soy food associated with lower risk of death and breast cancer recurrence, says new study

Results of two new studies support the use of intravenous Vimpat for patients in clinical settings

NeuroPace's RNS System effective for controlling seizures not treatable by medication in epilepsy patients

Long-chain omega-3 fatty acids can prevent colorectal cancer

Non-clinical data of CK-2017357 presented by Cytokinetics

$225,000 funding for promising epilepsy research

Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting

Gloucester Pharmaceuticals to be acquired by Celgene

UCB presents data on Vimpat AED at AES meeting

Scientists identify aggression-promoting pheromone in flies’ antenna

Researchers explore optimal induction therapies for managing blood cancer

DBS therapy offers hope for epilepsy patients

NPA responds to DEA's steroid classification action

AES: Progress in epilepsy management not reached millions of people around the world

Radio units help in optimizing medical device management in hospitals

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News